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ABSTRACT 
The transcription factor NF-κB interacts with many other co-regulator proteins that 
modulate its binding and transcriptional activity. One of these co-regulators, Pirin, is an iron-
dependent metalloprotein that has been shown to enhance the DNA binding of NF-κB 
homodimers. Here, we characterize the interactions between Pirin and its known NF-κB binding 
partners and examined the role of Bcl-3, a protein that is required for Pirin’s interaction with 
p50. In addition, we use site-directed mutagenesis to alter conserved residues within Pirin’s 
metal binding environment and observed how it affected the DNA binding and conformation of 
the Pirin-NF-κB complex. These studies show that, while a similar enhancing effect on DNA 
binding is observed, the interactions of Pirin with different NF-κB members are distinct from 
each other and could possibly have different physiological purposes.  
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1 INTRODUCTION 
The term “NF-κB” was coined in 1986 to describe an interactor of the κ light chain gene 
enhancer element in B cells
1, known as a κB site. Since then, it has been the subject of tens of 
thousands of publications and directly associated with over a hundred different stimuli and target 
genes in nearly every type of cell
2
.  NF-κB is a family of transcription factors (p50, p52, 
p65/RelA, RelB, and c-Rel) that form both homo- and heterodimers that are sequestered in the 
cytoplasm by inhibitory proteins in the IκB (inhibitor of κB) family and are released in response 
to cytokines or growth factors, among other stimuli
2
. Upon activation and translocation to the 
nucleus, NF-κB is capable of activating or inhibiting hundreds of genes involved in cell survival 
and proliferation.  With so many different sources of activation and genes that it can potentially 
affect, there is an obvious need for tight regulation of NF-κB activity so that only certain subsets 
of genes are activated in response to a specific cellular signal. To make this possible, NF-κB has 
many other proteins that it interacts with to modulate its activity, allowing the formation of a 
complex signaling network that integrates multiple pathways. One of these regulatory proteins, 
Pirin, will be the focus of this study. 
Pirin is a metalloprotein with two domains containing anti-parallel beta-sheets 
characteristic of the cupin superfamily of proteins (Figure 1.1)
3
. The cupin superfamily, one of 
the most functionally diverse families, includes both enzyme and non-enzyme members and 
contains proteins that have been seen to bind a variety of metals as well as no metal at all
4
. Pirin 
octahedrally coordinates an iron ion within its N-terminal domain (but not its C-terminal 
domain) with three histidine residues (H56, H58, and H101) along with a glutamate residue 
(E103)
3
. Two water molecules occupy the remaining coordination sites (Figure 1.2). The 3-His-
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1-Glu motif  is a deviation from the 2-His-1-Glu/Asp coordination seen in most other non-heme 
iron-dependent proteins and is somewhat rare
5
, but it can be found in other cupin family 
metalloprotein enzymes that share structural features with Pirin. In particular, oxalate oxidase 
and quercetin 2,3-dioxygenase share the same 3-His-1-Glu coordination of their metal ion and 
have a similar fold and binding pocket located at their metal binding sites that is present in Pirin, 
although these two enzymes have their coordinating Glu in a different position relative to their 
metal and utilize transition metals other than iron
3
.  
 
Figure 1.1: Structure of Pirin and other cupin family proteins (A) Pirin (PDB: 1J1L), (B) Cysteine 
dioxygenase (2IC1), (C) Quercetin 2,3-dioxygenase (1JUH), (D) Oxalate oxidase (1FI2). Note the anti-parallel β-barrel structures 
characteristic of this family. 
 
Even though Pirin was initially discovered as an interactor of the NFI/CTF box 
transcription factor
6
, the later finding that it is also an interactor of p50 homodimers in 
conjunction with Bcl-3, another NF-κB regulator, has attracted much more attention to this 
protein
7
.  Bcl-3, a member of the IκB family, serves as a bridging molecule between p50 
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homodimers and other coregulator proteins such as Tip60, Jab1, and Bard1. However, among 
these proteins, the p50/Bcl-3/Pirin complex was unique in displaying a significantly enhanced 
level of binding to the κB DNA sequence tested compared to p50 and p50/Bcl-3 alone7.  
 
Figure 1.2: Octahedral coordination of iron ion bound by Pirin 
 
In spite of being discovered over a decade ago, knowing other proteins it interacts with, 
and the 3-D structure and protein family being known, the relationship between the structure and 
function of Pirin remains relatively uncharacterized. Pirin and its orthologs found in other 
mammals, plants, fungi, and prokaryotes (but, interestingly, not yeast) contain no known 
functional motifs or significant sequence homology with other proteins. Even when aligned with 
its orthologs, Pirin displays only a low to moderate degree of sequence conservation outside of 
its iron-binding N-terminal domain (Figure 1.3)
6
. Most of the residues that show nearly complete 
conservation across all species are located in proximity to the metal center or within the binding 
pocket exposing the bound iron to the surface of the protein.  
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Figure 1.3: Sequence alignment of Pirin Alignment includes eukaryotic (XePirin, CapPirin, AraPirin, ZeaPirin) 
and prokaryotic (CCPirin, P1205Pir) homologs (NCBI identifiers listed in Materials and Methods). Metal ligands are highlighted 
in yellow, residues lining binding pocket surrounding metal highlighted in green. Obtained with CLUSTALW: 
http://www.ebi.ac.uk/Tools/msa/clustalw2/ 
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The Pirin orthologs found in plants and bacteria, which do not contain the same 
transcription factors as mammals and thus lack NF-κB and other proteins mammalian Pirin 
interacts with, have still been observed to have functions relating to cell survival that are similar 
to the functions associated with the NF-κB pathway in humans. An ortholog of Pirin found in the 
cyanobacterium Synechocytis was found to be upregulated in conditions of high salinity
8
 and, 
similarly, the expression of a homolog of Pirin found in tomatoes is increased in response to 
specific apoptosis-inducing stimuli
9
. 
Because of its central position in multiple signaling pathways, dysreguation of NF-κB has 
been implicated in many pathological conditions including cancer, inflammation, and septic 
shock
10,11
, making NF-κB an attractive target for drug development. Thus, as a modulator of NF-
κB binding, Pirin could also potentially be a target protein for the development of new therapies 
for disease. In particular, multiple studies have established links between Pirin and cancer
12-14
, 
although the exact signaling pathways involved or how Pirin affects their activity remains vague.  
Pirin’s role in oncogenesis, and perhaps the cell itself, is highly dependent upon the cell line 
being examined. The expression of Pirin varies greatly across different cancer cell lines
14,15
, 
generally showing higher expression in breast, cervical, lung, and skin cancers and reduced 
expression in colon cancer and leukemia cell lines. The significance of the expression levels of 
Pirin to a given type of cancer and its contribution to a cancerous phenotype is not clear-cut.  The 
development of specific types of cancer has been linked to both overexpression and the absence 
of Pirin. While the high expression of Pirin in subsets of melanoma cell lines contributes to the 
disease by inhibiting the senescence of melanocytes
15
, its reduced expression in leukemia cell 
lines has been found to inhibit cell differentiation, which is an underlying cause in the 
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development of acute myelogenous leukemia (AML)
12
. Knockdown of Pirin in melanoma cell 
lines that have high Pirin expression reverses the lack of senescence associated with these cells
15
. 
In addition, Pirin knockdown reduces the metastatic phenotype of these cells by causing a 
corresponding decrease in the expression of the SLUG protein
14
, further revealing its potential as 
a therapeutic target. A small-molecule inhibitor which binds to Pirin’s binding pocket in 
proximity to its metal center and disrupts its association with Bcl-3 has been shown to inhibit 
melanoma cell migration in a way similar to its siRNA knockdown, showing promise for future 
drug-development
14
.  
Since the discovery that Pirin interacted with p50 homodimers through Bcl-3 and 
enhanced DNA binding, almost no other information regarding the specific nature or mechanism 
of Pirin’s effect upon NF-κB has been published. Other coregulator proteins that interact with 
p50 through Bcl-3 have been linked to enzymatic functions. One of these proteins, Tip60, has 
been shown to have histone deacetylase activity
16
 and Bard1 is needed to stabilize BRCA1, a 
DNA-repair enzyme
17. Although Pirin’s metal binding site and putative binding pocket 
resembles that of other enzymes in the cupin superfamily, it has not been found to have a 
prominent enzymatic role in vivo. One study revealed that Pirin and one of its prokaryotic 
orthologs found in E. Coli, yhhW, is capable of quercetinase activity in vitro in a way similar to 
quercetin 2,3-dioxygenase
18
, and overexpressing Pirin in NKE cells increased the quercetin 
resistance of poliovirus replication in those cells
19
. However, the extent of how physiologically 
relevant Pirin’s quercetinase activity is, or whether or not it is an important factor in the 
regulation of NF-κB, has yet to be determined. Based on the evidence present at this time, it is 
likely that Pirin’s role with NF-κB is non-enzymatic.  
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Since its discovery, a majority of the investigation of Pirin has been primarily approached 
from a biological perspective. While this has identified its role as a transcriptional regulator and 
a possible oncogene, it has left the questions surrounding the specific mechanisms of Pirin’s 
interactions with NF- κB and DNA relatively untouched. An aspect of Pirin’s function that has 
received little attention is its potential interactions with other NF-κB members, which have a 
similar overall structure to p50. It was initially believed that Pirin only interacted with p50 in a 
Bcl-3 dependent manner. However, our group has found that Pirin interacts with p65 
homodimers as well as p50 homodimers and confers a similar enhancing effect on the ability of 
p65 to bind DNA (Liu, unpublished data). Interestingly, unlike p50 homodimers, the interaction 
with p65 does not require Bcl-3, which only interacts with NF-κB dimers consisting of p50 or 
p52
20
.  This would imply that the interactions with p50 and p65 are distinct from each other and 
may have different characteristics such as stoichiometry, the structural features of the 
protein/protein or protein/DNA complexes, or mechanism of action. These two members of the 
Rel family have distinct differences in the consensus sequence they favor, the proteins they can 
potentially interact with, and overall physiological function. With at least two NF-κB dimers that 
it can interact with, Pirin’s potential role in cell signaling has been expanded greatly. With the 
aforementioned differences between p50 and p65, along with the different compositions of their 
known complexes with Pirin, understanding the differences in the nature of Pirin’s interactions 
with these two proteins will help facilitate future studies that form more precise links between 
Pirin and its physiological role.  
The focus of this study will be to obtain an initial characterization of the complexes Pirin 
forms with p50 and p65 to find distinguishing characteristics between the two interactions.  In 
addition, the effects of mutations in Pirin’s metal-binding environment will also be examined to 
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gain more insight on how this highly conserved region, and perhaps the metal itself, contributes 
to Pirin’s function. These topics will be addressed from a perspective that focuses on the 
conformation of the Pirin-NF-κB-DNA complex in addition to how much it enhances the DNA 
binding of NF-κB. As we will learn in the next chapter outlining the structure and function of 
NF-κB, the conformation of an NF-κB-DNA complex is crucial in determining its activity and 
varies from one promoter site to another. Thus, by studying changes conformation in conjunction 
with DNA binding resulting from mutagenesis, we are able discern between protein-DNA 
complexes that resemble the wild-type and are likely to be transcriptionally active in vivo and 
those that might be binding incorrectly.  
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2 NF-κB: STRUCTURE, FUNCTION, AND REGULATION 
2.1 Overview 
Even after over two decades of intensive study and over 36,000 publications on the 
subject, NF-κB remains a highly active area of research with many unanswered questions. The 
five NF-κB proteins (p50, p52, p65/RelA, RelB, c-rel) display a remarkable versatility that 
allows them to participate in numerous signaling pathways and physiological responses, some 
which appear to contradict each other such as how NF-κB activity has been shown to promote 
both cell survival and apoptosis. This versatility is due to the myriad layers of regulation that 
fine-tune NF-κB activity across different cell types and physiological conditions.  
The most basic level of regulation over the NF-κB response is that the five proteins can 
form many different dimer combinations that are similar in overall structure but have different 
preferences for the DNA sequences they bind and non-redundant functions. Thus, a cell 
producing a greater amount of one type of subunit would have a direct influence on the genes 
that are likely to be activated or repressed. 
Interactions with other proteins provide a much more complex layer of regulation and 
influence how NF-κB dimers are activated by various stimuli, how they are deactivated, and how 
they influence other signaling pathways through direct interaction with other transcription 
factors.  
In addition to the above methods of NF-κB regulation, the DNA sequences themselves 
have been shown to also play a role in determining the exact action an NF-κB-DNA interaction 
will yield. The κB consensus sequence that NF-κB binds to is remarkably flexible, with a single 
base pair substitution being capable of affecting the conformation and activity of a bound NF-κB 
complex
21
.  
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This chapter will attempt to review the fundamentals of NF-κB structure and function as 
well as go into more detail on the different layers of regulation mentioned above.  
2.2 Structural Features 
As mentioned previously, the term NF-κB is given to any hetero- or homodimer 
combination of five proteins: p50, p52, p65/RelA, RelB, and c-Rel. The defining feature of the 
NF-κB family is a 300 amino acid sequence at their N-terminal domain referred to as the Rel 
homology domain (RHD) which consists of a pair of immunoglobin-like domains which are 
required for dimerization, nuclear localization, and DNA binding. (Figure 2.1)  
 
Figure 2.1: Structure of the RHD of p50 
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Figure 2.2: Comparisons of the dimerization domains of NF-κB. (A) Dimerization domain of NF-κB 
Rel homology domains highlighted with red box (p65 homodimer shown, PDB code 1RAM); (B) Asp 254 and Asn 200 interact 
more favorably with each other in p50/p65 heterodimers (pink) than they do when they are paired with copies of themselves in 
p50 (blue) and p65 (green) homodimers; (C) Additional hydrogen bonding contributed by Y267 in p50 (blue), p65 shown in 
green 
 
NF-κB proteins form dimers through hydrophobic interactions along a β-sheet interface 
between the C-terminal domains of each subunit’s RHD (Figure 2.2A).  These hydrophobic 
dimer interfaces are highly conserved across the NF-κB family members, allowing most dimer 
combinations to exist in physiological conditions
22
. However, there are minor differences 
between the dimerization domains of each NF-κB protein that make some members more 
complimentary for each other than others, thus making them more stable and increasing their 
population relative to other dimer combinations. The p50/p65 heterodimer, the most common 
NF-κB dimer combination, is more stable than the homodimers of either subunit due to a 
favorable interaction between Asp 254 of p50 and Asn 200 of p65 that does not exist in the 
homodimers
23
 (Figure 2.2B).  The dimerization interface of p50 and p65 homodimers share 
11 
 
 
many of the same residues, but a few minor differences make p50 homodimers more stable
22
. 
F213 in p65 is replaced with a tyrosyl (Y267) in p50, which further stabilizes the p50 
homodimer with the additional hydrogen bonding contributed by the hydroxyl group (Figure 
2.2C). Also, F307 in p50 is replaced with V248 in p65, which reduces the hydrophobic 
interaction contribution to the stability of the p65 homodimer.  
The dimer combinations that do not exist in vivo are those that contain RelB, which has 
structural features that set it apart from the other NF-κB subunits which includes an additional N-
terminal leucine zipper domain and a patch of nonpolar residues at its surface. RelB forms 
intertwined homodimers that are unstable in physiological conditions and are hypothesized to 
exist only transiently as a way of avoiding degradation until it can form a stable heterodimer
24
. 
RelB has not been found to form heterodimers with p65 or c-rel, but can form stable 
heterodimers with either p50 or p52
25
 and are important in specific NF-κB signaling pathways, 
which will be discussed later.    
While the RHDs and the DNA binding motifs of each NF-κB protein are similar to each 
other, the C-terminal domains have crucial differences that further specify the roles of each 
family member. NF-κB proteins can be divided into two groups: the proteins containing a 
transactivation domain (TAD) at their C-terminal (p65, RelB, and c-Rel) and the proteins that 
lack a TAD (p50 and p52) (Figure 2.2). Thus, homodimers of p50 and p52 are typically 
repressors of transcription while dimers containing p65, RelB, and c-Rel are transcription 
activators in most cases
26
.  
Another difference between the two groups of NF-κB proteins is that p50 and p52 are 
processed from larger proteins named p105 and p100, respectively
27,28
. p105 and p100 contain 
multiple ankyrin repeat domains (ARDs),  a structural motif shared by all members of the 
12 
 
 
inhibitor of κB (IκB) family, and are capable of interacting with other NF-κB proteins and 
sequestering them in the cytoplasm. 
 
 
Figure 2.3: Structural domains of NF-κB family members. RHD: Rel homology domain, TAD: 
transactivation domain, LZ: leucine zipper motif. Taken from Wan, 200929. 
 
2.3 Primary components of the NF-κB activation pathway 
While the different dimer combinations are selectively activated by specific stimuli, they 
all reside in the cytoplasm in an inactive form and are shuttled to and from the nucleus in a 
regulated manner
30
. With the exception of p50/RelB and p52/RelB heterodimers, NF-κB 
activation is accomplished through what is referred to as the “canonical” pathway. To briefly 
summarize, this pathway is initiated by a membrane receptor protein being stimulated by its 
ligand which activates IκB kinase (IKK), resulting in the degradation of the IκB protein that 
sequesters the NF-κB dimer in the cytoplasm, allowing it to translocate to the nucleus where it 
can activate or repress transcription accordingly (Figure 2.3). 
12 
 
 
 
Figure 2.4: Scheme of canonical NF-κB activation 
 
IKK has three different subunits: IKKα and IKKβ, which serve a catalytic role, and 
IKKγ/NEMO, which has no catalytic activity but plays a regulatory role31. IKK targets IκB 
proteins, resulting in their degradation by the 26S proteasome and release of the NF-κB dimer it 
was bound to
30
.  IKK is activated in response to stimulation of receptor proteins by various 
cytokines, such as TNF-α and IL-1, and IKKγ recruits kinases that phosphorylate the IKKβ 
subunit to fully activate the IKK complex. Once activated, the IKK complex phosphorylates 
13 
 
 
conserved serines on IκB proteins that sequester NF-κB dimers in the cytoplasm, causing their 
degradation. Phosphorylation of IκB by IKK is the only regulated step in its degradation32, thus 
dysregulation of IKK has deleterious consequences such as tumor development
33
.  
The IκB family has five members (IκBα, IκBβ, IκBε, p105, and p100) that are considered 
to be “typical” IκB proteins since they operate in the same general manner by binding to the 
RHDs of NF-κB dimers with their ARDs and rendering them inactive. Two more “atypical” IκB 
family members exist: IκBζ and Bcl-3. These atypical members, while sharing structural features 
with other members of the IκB family, do not repress NF-κB activity in the same way and 
instead act primarily as coregulator proteins that can potentially activate transcription as well as 
repress it.  Bcl-3 will be discussed further in another section. Another structural feature present 
in many IκB members that is absent in Bcl-3 is the C-terminal PEST domain, a disordered region 
rich in proline, glutamate, serine, and threonine
34
. This region is constitutively phosphorylated 
and is thought to be important for both protein function and stability
35
. 
It was originally believed that IκB proteins were only important in the cytoplasm, 
inhibiting NF-κB dimers by concealing their nuclear translocation domains. While that is still an 
important aspect of NF- κB inhibition, it was later found that IκB proteins also act in the nucleus 
by removing DNA-bound NF-κB and that the IκB-NF-κB complex was capable of being shuttled 
back and forth between the cytoplasm and the nucleus
36
. The gene for IκBα is activated by NF-
κB itself, creating a feedback loop that ensures that NF-κB activation is transient37. After NF-κB 
activation, IκBα is produced to replace that which was degraded and binds to the NF-κB dimers 
attached to their κB sequences, removing them and shuttling them back to the cytoplasm where 
they await activation once again. Each IκB family member has a preference for which NF-κB 
dimer it interacts with, although it has been observed that their possible binding partners do have 
14 
 
 
some overlap
38
. There are also differences in the kinetics of their activation. IκBα is rapidly 
produced in response to NF-κB activation while IκBβ and IκBε take more time to accumulate, 
allowing for the length of an NF-κB response to be regulated38.  
Upon stimulation by cytokines or other inducers of NF-κB activity, IκB proteins are 
phosphorylated at specific residues (Ser32 and Ser36 in the case of IκBα39). This 
phosphorylation event targets them for ubiquitination, which makes them substrates for the 26S 
proteasome and results in their degradation
40
. Once released from IκB repression, the NLS of the 
NF-κB dimer is exposed and can be translocated to the nucleus.  
2.4 Interaction with DNA 
The target gene sequences of NF-κB dimers, referred to as κB sites, generally conform to 
the consensus sequence 5’-GGGRNWYYCC-3’ where R, N, W, and Y represent purines, any 
base, A or T, and pyrimidines, respectively. Many κB sites only loosely conform to the 
consensus sequence, resulting in a very broad assortment of identified κB sites for different 
genes (Table 2.1).  
Table 2.1: Examples of Class I and II κB sequences 
Class I Sequences                                     
IgκB  5’-GGGAC T TTCC-3’ 
IFN-β 5’-GGGAA A TTCC-3’ 
IL-6 5’-GGGAT T TTCC-3’ 
Class II Sequences  
κB-33 5’-GGAA AT TTCC-3’ 
IL-2 5’-A AGAA T TTCC-3’ 
IL-8 5’-T GGAA  T TCCC-3’ 
15 
 
 
 
As one would expect, the sequence of a κB site determines its preference for which NF-
κB dimer combination it interacts with. Similar to how NF-κB subunits can be divided into two 
groups based on their structural domains, κB sites can be divided based on whether they prefer to 
interact with p50 or p65. The RHDs of NF-κB subunits are mostly similar from one family 
member to another, but small differences between their DNA binding domains result in p50 and 
p52 preferring 5’-GGGRN-3’ sequences and p65 and c-rel having a preference for 5’-YYCC-3’ 
sequences. Combined, these two half-sites form the κB consensus sequence. Each monomer unit 
of an active NF-κB dimer is capable of binding half of a κB site. Since p50/p65 is the most 
common NF-κB dimer combination, the ideal consensus sequence is a 10 bp sequence contains 
the 5 bp sequence targeted by p50 or p52 and the 4 bp sequence preferred by p65 and c-rel 
connected with an A-T bp in the center. κB sequences that have a preference for homodimers are 
composed of either two of the 5 bp half sites, resulting in an 11 bp sequence that attracts p50 or 
p52 homodimers, or contain two of the 4 bp sites in a 9 bp sequence that attracts p65 or c-rel 
homodimers. The 10 or 11 bp sequences are referred to as Type I κB sites while the 9 bp 
sequences that prefer p65 or c-rel homodimers are referred to as Type II sites.  
NF-κB interacts with DNA in a somewhat unusual way that is not classified by any of the 
typical motifs seen on DNA-binding proteins (helix-turn-helix, helix-loop-helix, etc.). Instead of 
binding DNA through α-helices that are inserted into DNA grooves, NF-κB uses an 
immunoglobin-like fold that consists of β-sheets and large connecting loops that interact with the 
major groove
41
 (Figure 2.5). The key residues responsible for the specific protein-DNA contacts 
are mostly similar between NF-κB subunits. In p50 they are R54, R56 Y57, E60, H64, and K241, 
most of these residues are conserved in p65 with the exception of H64, which is replaced with an 
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alanine
23
. This minor alteration is the primary reason for the different half site preferences of p50 
and p65 subunits
23
. H64 hydrogen bonds with the additional G-C base pair found in Type I sites, 
creating a more favorable interaction that is absent in p65.  
 
Figure 2.5: NF-κB uses flexible loops to recognize and interact with DNA. p65 bound to DNA 
shown (PDB: 1RAM). DNA-binding loops highlighted in red.   
 
The loose adherence of κB sequences to the consensus sequence is made possible by the 
flexible nature of the RHD.  NF-κB homodimers, which should ideally bind κB sequences that 
are symmetrical to reflect that each half of the dimer has the same DNA binding preferences, are 
still able to have high binding affinity for asymmetrical sites because of the flexibility allowed 
by the linker region connecting the two domains of the RHD that enables the subunit that 
contacts the non-ideal half of the κB site to rotate its conformation to accommodate the sequence 
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and form contacts with the DNA backbone
42
. These non-base-specific contacts allow for an NF-
κB homodimer that only forms base-specific contacts with half the κB site to still bind the DNA 
with a high affinity. This binding mechanism is what allows p50 and p65 homodimers to bind to 
the IgκB sequence, which includes half-sites for both p50 and p65 and normally prefers p50/p65 
heterodimers.  
As our understanding of NF-κB has developed over the past two decades, the importance 
of the sequence of a κB site has become more apparent. Because of NF-κB’s flexibility, the κB 
sequence itself is very pliable and is still recognizable by NF-κB if a few base-pairs deviate from 
the consensus sequence. This would suggest that there would not be many consequences 
resulting from a single base-pair mutation. But, in spite of the flexibility of the κB consensus 
sequence and the diversity of κB sequences found in the genome, a κB site in the promoter of 
any specific gene displays almost complete conservation from one species to the next. If the 
sequence of a κB site were truly flexible, one would expect a lower level of sequence 
conservation. Consistent with this observation, multiple studies have revealed that even a single 
base pair mutation in a κB site has significant effects upon both the structure42 and function43 of 
the NF-κB/DNA complex. Crystal structures of NF-κB bound to different κB sequences has 
revealed that changing the sequence of a κB site by even a single base pair will also change its 
structure, resulting in a different conformation of the protein-DNA complex when NF-κB binds. 
An example is the difference in the conformation of a p50/p65 heterodimer bound to the IgκB 
sequence
23
 and one bound to the IFN-β sequence44. These are both Class I κB sequences, each 
containing a consensus half-site for p50 (5’-GGGRN-3’) and p65 (5’-TTCC-3’). The sequence 
for IFN-β (5’-GGGAAATTCC-3’) only differs from IgκB (5’-GGGACTTTCC-3’) by only the 
two underlined base pairs. However, as seen in Figure 2.6, this relatively small alteration in 
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DNA sequence translates to significant differences in the conformation of the NF-κB 
heterodimer bound to it. 
 
Figure 2.6: Small changes in a κB sequence affect the conformation of DNA-bound NF-κB. 
p50/p65 homodimer bound to IgκB (red, PDB: 1VKX) and IFN-β (blue, PDB:1LE5).  
 
 This illustrates how the protein-DNA complex can vary greatly between individual genes 
regulated by the same NF-κB dimer21. The structural conformation of a protein-DNA complex is 
important for the recruitment of transcription co-factors, such as Pirin, creating the diverse co-
factor requirements observed between genes that are regulated by the same NF-κB dimer 
combination.  
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2.5 Interaction with other Bcl-3 and other proteins 
In addition to the sequestration and activation of NF-κB in response to various stimuli, 
there are numerous coactivator and corepressor proteins that further modulate NF-κB activity 
once it is active and within the nucleus. NF-κB alone cannot activate transcription; it requires the 
recruitment of multiple coactivator proteins to form a transcriptionally active enhancer 
complex
45
. NF- κB coregulator proteins include both enzymes and non-enzymes and the proteins 
required for transcription at a given promoter are determined by both the NF-κB dimer 
combination and the sequence of the promoter, which affects the conformation of the NF-κB 
dimer
21
.  
There are dozens of known protein-protein interactions that NF-κB is involved in; even 
some that include other transcription factors. This section will primarily focus on Bcl-3, the 
protein that is required for Pirin to interact with p50 homodimers, as well as a few of the more 
prominent coregulators of p65.   
Bcl-3 is considered as a member of the IκB family due to its sequence similarity and the 
presence of ARDs that interact with the RHD. However, unlike other IκB proteins, the result of 
Bcl-3 interacting with NF-κB does not necessarily result in inhibition. The PEST domain present 
in IκBα that is required for its interaction with NF-κB is absent in Bcl-3, being replaced by an 
additional ARD (Figure 2.7). Another important difference is that Bcl-3 is primarily located 
within the nucleus while other IκB proteins are mostly cytoplasmic and are shuttled between the 
two cellular compartments. 
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Figure 2.7: Structures of IκBα and Bcl-3 
 
Bcl-3, which exclusively interacts with p50 and p52, contains a TAD that we now know 
can potentially give transcriptional activity to these NF-κB subunits that normally lack it46. 
However, whether or not Bcl-3 was an activator or inhibitor of transcription and the specific 
mechanism behind its activity was initially a subject of controversy.  Early studies suggested that 
Bcl-3 influenced transcription of NF-κB-regulated genes by inhibiting the binding of p50 
homodimers to DNA
47
 and that Bcl-3 could bind to and remove inhibitory p50 homodimers that 
lacked a TAD from DNA, allowing the binding of dimers containing a TAD
48
. Other studies 
presented opposite findings, revealing that Bcl-3 activated transcription in a p50-mediated 
process
49
. The discrepancy between these findings was found to be due to variations in the 
sources of their recombinant Bcl-3 as well as differences in truncations. Along with its ARDs, 
Bcl-3 has regions at both the N and C-terminus that are highly phosphorylated in vivo. 
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Constructs of Bcl-3 that contain these regions show a streaked gel migration pattern, indicating 
the variable degrees of phosphorylation, while truncated versions that only contain the ARDs 
migrate as a single band due to the lack of phosphorylation
49
. The transactivation function of 
Bcl-3 is dependent upon its phosphorylation, so truncated Bcl-3 that only contained the ARDs or 
recombinant Bcl-3 expressed in bacteria or insect cells where they would undergo the necessary 
post-translational modifications displayed an inhibitory effect while Bcl-3 expressed in 
mammalian cells was capable of activating transcription via p50 homodimers
49
.  
Bcl-3 has been studied for almost as long as NF-κB has, but its biological function still 
remains somewhat unclear. Bcl-3 knockout mice were still viable and were only noticed to be 
more susceptible to infection, similar to the phenotype observed in p50 knockout mice
50
 which 
indicated that Bcl-3 acts through p50 in its role in immunity. However, the phenotypes of Bcl-3 
and p50 deficient mice do not overlap completely, with Bcl-3 deficient mice having 
abnormalities in their spleens while mice lacking p50 have normal spleens, so Bcl-3 also has 
p50-independent functions. Constitutive expression of Bcl-3 in LyH7 and BAF-B03 cells 
increased nuclear translocation and DNA binding of p50 homodimers, but this effect was found 
to be dependent on cell type and is proposed to require a significant pool of p50-p105 
heterodimers in the cytoplasm for Bcl-3 to act upon
51
. Although previously mentioned studies 
showed a transactivating role for Bcl-3, later studies revealed that it could potentially act as a 
repressor of IL-2 expression in tolerant CD4
+
 T cells
52
.  
 Bcl-3 also has been found to act as a bridging molecule from p50 homodimers to other 
proteins, such as Pirin
7
. Initially, four proteins (Pirin, Tip60, Jab1, Bard1) were found to interact 
with p50 in a Bcl-3 dependent manner. Pirin greatly increased the amount of DNA binding by 
p50, although whether or not it increased transcription activity was not tested in that study. On 
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the other hand, the histone acetyltransferase (HAT) Tip60 did not increase DNA binding but did 
increase transcriptional activity. Recently, IRS-3 was also found to use Bcl-3 as a bridging 
molecule to interact with p50 homodimers and increased the DNA binding of p50 in a manner 
similar to Pirin
53
. The same study found that IRS-3 increased the activity of p50 as well, but only 
in a TNF-α dependent manner. IRS-3, while it increases the DNA binding and activity of p50 
homodimers, was not detected in the protein-DNA complex during immunoprecipitation, 
suggesting that its interaction with Bcl-3 and p50 is transient. This is an important difference 
from Pirin, which was demonstrated to remain in the DNA-bound complex with p50 and Bcl-3.  
p65 also has many proteins that interact with it, some that are required for its activity on 
certain promoters. Chromatin remodeling by HATs have been known to promote the binding and 
activity of transcription factors by loosening the chromatin structure. The HAT Tip60, which 
was previously mentioned as one of the proteins that interacts with p50 homodimers via Bcl-3, 
also interacts with p65 homodimers and promotes its binding and activation of specific promoter 
sites
54
 and is another example of a protein that requires Bcl-3 when bound to p50 but can 
associate with p65 on its own. Curiously, Tip60 interacts with the N-terminal domain of p65’s 
RHD instead of the C-terminal domain, which is where it would associate with Bcl-3 and p50.  
 Another HAT that also functions as a bridge between p65 and the basal transcription 
machinery is CBP and its homolog p300. CBP/p300, which has many known interactions with 
other transcription factors
55,56
, was found to also interact directly with the C-terminal 
transactivation domain of p65 and enhanced p65-dependent transcription
57
.  Along with its HAT 
activity that modifies chromatin structure
58
, CBP/p300 can connect p65 to neighboring 
transcription factors bound to other promoters on a gene, allowing the transcription factors to 
have a synergistic relationship and work together as a single unit as seen in the IL-6 promoter
59
. 
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Phosphorylation of S276 on the RHD of p65 by protein kinase A (PKA) has been shown to be 
needed for efficient binding of CBP/p300 to p65
60
, illustrating how post-translational 
modifications by other proteins also contribute to the regulation of NF-κB signaling.  
 Just as HATs act as coactivators of NF-κB activity, histone deacetylases (HDACs) act as 
repressors of gene expression. HDAC1 and HDAC2 were found to interfere with p65 activity, 
although only HDAC1 was found to interact directly with p65 while HDAC2 only bound to 
HDAC1 to form a complex
61
.  
 Sometimes, the coactivators of p65 are transcription factors that have their own promoter 
sites and are independent from NF-κB under a different context. One example of this is p65’s 
interaction with Fos and Jun members of the AP-1 transcription factor family, which act 
synergistically to enhance DNA binding and activation at certain promoters
62
.  
2.6 Summary 
While the mechanisms that sequester and induce NF-κB signaling exist in the cytoplasm, 
activation and translocation of NF-κB to the nucleus to bind a DNA sequence in response to a 
stimulating signal is only the beginning of what ultimately determines the physiological result of 
the protein-DNA interaction.  The κB sequence itself, which has dozens of variants, acts as an 
allosteric regulator of NF-κB by affecting the conformation of the bound protein.  The flexible 
linker region connecting the two domains of the RHD makes this possible by allowing an 
amazing level of conformational versatility when recognizing κB sequences and modifying the 
orientation of the RHD domains relative to DNA to form an optimal interaction with suboptimal 
sequences. Furthermore, by each NF-κB-DNA complex having a different conformation, it 
allows for selectivity among the many protein coregulators of NF-κB which modulates the 
activity of the promoter complex by enhancing or repressing its expression. When these factors 
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are combined, it creates a highly complex system of regulation that allows only five NF-κB 
proteins to selectively activate or repress hundreds of genes at a promoter-specific level.  
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3 RESULTS 
3.1 Introduction 
As we have described in the previous chapter, not only is the binding of an NF-κB dimer to 
a κB sequence important but the resulting conformation of the NF-κB/DNA complex is also 
important in determining the outcome of the interaction.  p65 homodimers, which contain a 
TAD, are normally considered potent activators of transcription. However, in the case of IL-2, 
p65 homodimers compete with the transcription factor NF-AT for binding to its DNA sequence, 
which is similar enough to the κB consensus sequence to function as a low-affinity site for p65. 
Increasing expression of p65 results in reduced expression of IL-2
63
, illustrating how DNA 
binding by a NF-κB dimer containing a TAD is not always sufficient for transcription. 
Furthermore, when inhibiting Pirin with a small molecule inhibitor and analyzing changes in 
gene expression, Pirin inhibition resulted in an 0.8 fold increase of IL-8 expression
14
, which is a 
gene containing a Class II κB promoter sequence that is regulated by p65 and implies that Pirin 
could potentially have a repressor function as well as an activating one. Therefore, when 
studying Pirin and its interaction with NF-κB, especially when in vitro techniques that study the 
interaction outside the context of gene expression, it is important to consider how the Pirin/NF-
κB complex is interacting with DNA in addition to how much of that interaction is taking place.  
Learning how Pirin affects the interaction and conformation of different NF-κB dimers can 
contribute to a greater understanding of Pirin’s structural features as well as its physiological 
role. Keeping this in mind, this study will address the following questions: 
 How does Pirin alter the conformation of NF-κB and the NF-κB/DNA complex? 
 In what significant ways are the interactions of p50 and p65 with Pirin different 
from each other? 
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 How does Pirin’s metal-binding environment contribute to the conformation of 
these higher order complexes? 
These questions are primarily studied using quartz crystal microbalance with dissipation 
(QCM-D). QCM-D, similar to surface plasmon resonance (SPR), is capable of monitoring very 
small changes in mass added to a sensor surface modified to capture a specific ligand/molecule, 
making it ideal for studying binding activities of biomolecules. For this study, κB DNA was 
immobilized onto the surface of the QCM-D sensor and the binding of NF-κB and/or Pirin to the 
DNA was measured by the change in mass added to the sensor. Unlike SPR, which strictly 
measures changes in mass, QCM-D can also measure how rigid or floppy the mass attaching 
itself to the sensor is. Layers on the sensor surface formed by a well-organized protein-DNA 
complex that show less freedom of conformation are distinguishable from less-organized layers 
that are in a less rigid conformation, thus giving information on the conformational nature of a 
protein-DNA interaction as well as its quantity. (For a more detailed explanation of the QCM-D 
technique and how to interpret data obtained from it, please refer to the appendix.) 
To supplement the structural information obtained with QCM-D, which only measures 
the overall conformation of the protein-DNA layer and cannot differentiate between protein-
protein and protein-DNA interactions, circular dichroism (CD) spectra in both the near and far 
UV regions are also obtained. While CD also has the limitation of being unable to determine the 
specific locations of the conformational changes taking place, contributions from protein and 
DNA to a change in conformation can be looked at separately by taking advantage of the 
dominance of protein secondary structure in the features seen in the 200-260 nm region and the 
dominance of DNA secondary structure in the 260-320 nm region.  
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3.2 Alteration of NF-κB-DNA conformation by Pirin 
Pirin was first observed to enhance the binding of p50 homodimers to the MHC enhancer 
sequence (5’-GGGGATTCCCC-3’)7. We have previously found that Pirin is also capable of 
interacting with p65 homodimers and has a similar enhancing effect upon its ability to bind the 
IgκB sequence (Liu, unpublished). Interestingly, Pirin’s interaction with p50 homodimers 
requires the presence of Bcl-3
7
 while its interaction with p65 does not appear to require any other 
protein, suggesting that these two NF-κB proteins interact with Pirin differently.  
To explore this possibility, QCM-D was utilized to examine the DNA binding affinity 
and conformation of p50 and p65 homodimers and how these characteristics were altered by 
Pirin.  The IgκB sequence was immobilized to the sensor surface through a biotin-streptavidin 
linkage (Figure 3.1). When flowing the Pirin/NF-κB complex over the immobilized DNA, 
binding of the DNA results in an increase in mass deposited on the sensor and causes a 
corresponding shift in frequency (Δf).  
 
Figure 3.1: Preparation of QCM-D sensor surface. A biotin-functionalized QCM-D sensor (purchased from 
Q-Sense) was sequentially treated with streptavidin and biotinylated DNA 
  
 Consistent with both published results and our own previous results, the increased shift in 
frequency indicates that adding Pirin to p50-Bcl-3 or p65 increases the amount of protein bound 
to the DNA immobilized to the QCM-D sensor (Figure 3.2). While Pirin increases the mass of 
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the complex binding DNA which results in a larger shift in frequency per unit bound, assuming 
that one monomer of Pirin binds each NF-κB subunit the increase in frequency is beyond what 
one would expect if the effect was only due to the increase in mass.  
 
Figure 3.2: Pirin enhances the DNA binding of p50 and p65 homodimers Pirin was incubated with 
p50 and Bcl-3 or p65 at room temperature before flowing over QCM-D sensor at 0.1 mL/min. (n=3) 
 
To obtain more information on the characteristics of the protein-DNA layer of the 
Pirin/p50/Bcl-3 and Pirin/p65 complexes, the shear and viscosity of each measurement was 
modeled using Q-Tools software. The shear and viscosity of a protein-DNA layer describes how 
easily the shape and structure of the layer is deformed when shear stress is applied. Higher shear 
and viscosity values indicate that the layer is more resistant to shear stress, making it likely that 
the layer is more dense, stiff, and/or organized and has a more constrained conformation. Lower 
values, meaning the layer is less able to resist shear stress, would indicate that the layer is less 
dense and organized and likely has higher water content. Low shear values could also result from 
incomplete coverage of the layer, giving the bound proteins more conformational freedom in 
response to shear stress without a neighboring protein-DNA complex to restrict its movement.  
Comparing the effect of wild-type Pirin on the shear and viscosity of p50/Bcl-3 and p65, 
it appears that Pirin greatly increases the shear of the p50/Bcl-3 complex (about seven-fold 
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higher), suggesting that it stabilizes the interaction of the protein complex to DNA and forms a 
rigid, organized layer (Table 3.1). Conversely, the Pirin/p65 complex has a lower shear and 
viscosity than p65 alone. This difference between Pirin’s apparent effect on p50 and p65 can 
partially be explained by the p65-DNA complex having higher shear and viscosity values than 
the p50-Bcl-3-DNA complex. This can possibly be attributed to this experiment using 
recombinant Bcl-3 that was obtained from bacteria, which is truncated to only include the ARD 
segment of the protein and does not include the flanking regions that are normally 
phosphorylated in mammalian cells. Unlike Bcl-3 produced in mammalian cells, 
unphosphorylated recombinant Bcl-3 has been known to inhibit or remove p50 homodimers from 
DNA and could be making the interaction between the p50-Bcl-3 complex and DNA unstable 
until Pirin is present and forms the complete, stable complex.  
 
Table 3.1: Viscoelastic properties of Pirin-NF-κB-DNA complexes 
 Shear (fold of NF-κB) Viscosity (fold of NF-κB) 
p50 + Bcl-3 + Pirin 7.729 ± 0.7137 1.564 ± 0.3510 
p65 + Pirin 0.3256 ± 0.0535 0.5051 ± 0.0051 
 
Adding Pirin to p65 reduces the shear and viscosity, but this can be attributed to Pirin 
doubling the size of the protein complex bound to DNA, creating a thicker layer containing more 
trapped water that is more likely to give lower modeled values for shear and viscosity than the 
smaller complex. However, it is notable that adding Pirin to the p50/Bcl-3 complex would also 
make it significantly bulkier but the shear/viscosity values drop significantly in spite of this, 
showing how powerful the stabilizing effect of Pirin is upon p50.  
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To verify the structural change induced by Pirin interacting with p65, circular dichroism 
was used to detect new secondary structure features resulting from interaction with Pirin. To do 
this, the CD spectrum of a mixture of Pirin and p65 were taken and had the individual spectra of 
each protein subtracted. Anything remaining on the spectra after subtraction is a result of a 
change in the secondary structure of one or both of the proteins.  
 
Figure 3.3: Additional CD spectra features seen with p65-Pirin interaction. (A) Spectra of Pirin 
and p65. Calculated sum of spectra plotted in brown, actual spectra of Pirin + p65 obtained experimentally plotted in green; (B) 
Difference spectra of p65 and 2.5 and 5 μM Pirin 
 
 The individual CD spectra of Pirin and p65 have a broad peak extending from 212 nm to 
222 nm, characteristic of proteins that have a mixture of α-helices and β-sheets. As seen in 
Figure 3.3A, there is a small, but reproducible, change in the CD spectra of Pirin and p65 
measured together from the sum of the two individual spectra. The difference spectra (Figure 
3.3A and 3.3B) shows a broad negative peak ranging from 210 to 220 nm, indicating that the 
changes in conformation involve both α-helices and β-sheets. Adding a lower concentration of 
Pirin to p65 results in a smaller negative peak (Figure 3.3B).  
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Figure 3.4: Effects of DNA binding on conformation of p65 and p65-Pirin. (A) Far UV CD spectra 
of p65 and p65 + DNA; (B) Far UV CD spectra of p65 + Pirin and p65 + Pirin + DNA; (C) Comparison of difference spectra of 
p65 + DNA and p65 + Pirin + DNA; (D) Near UV spectra of DNA, p65+ DNA, and p65 + Pirin + DNA. The spectrum for DNA 
was subtracted from all far UV measurements involving both DNA and protein. Protein spectra were subtracted from all near UV 
measurements.  
 
 DNA binding also has an effect on the conformation of p65 (Figure 3.4A). NF-κB 
proteins are known for their conformational flexibility that allows them to recognize a wide 
range of κB sequences42. Interestingly, binding DNA has a smaller effect on the Pirin-p65 
complex than it does with p65 alone (Figure 3.4B and 3.4C). Comparing the difference spectra of 
the two protein-DNA complexes (Figure 3.4C) also reveals that not just the magnitudes of the 
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two negative peaks are different; the shapes of the peaks show differences as well. The 
difference spectrum from adding DNA to p65 has a broad signal between 210 and 222 nm, 
similar to the difference spectrum seen in Figure 3.3B. However, the peak minimum of the 
difference spectrum of the p65-Pirin-DNA complex is shifted forward to about 225 nm and the 
peak itself is not as broad. The similarity in shape and magnitude of the difference spectrum of 
p65+DNA compared to p65+Pirin could suggest that p65 has an optimal conformation for 
binding this particular κB sequence that takes place upon DNA binding. However, Pirin could 
induce that conformation on its own, making the Pirin-p65 complex bind the κB sequence more 
favorably with less conformational change required.  
 Another interesting observation is that Pirin, when complexed with p65, appears to alter 
the secondary structure of DNA (Figure 3.4D). Features seen at wavelengths longer than 260 nm 
on CD spectra are dominated by DNA when it is present. Protein structural features such as 
aromatic residues and disulphide bonds also contribute to the signal in this region, but the 
concentration of protein used in these experiments (5 μM or less) makes their contribution 
negligible.  Therefore, the effects on DNA secondary structure can be isolated from the changes 
in protein secondary structure. The signal of IgκB was compared to the signal of p65 + IgκB and 
p65 + Pirin + IgκB. The spectra of each protein were subtracted before comparison. By itself, 
p65 induces a small decrease in the magnitude of the peak at ~275 nm. However, when 
complexed with Pirin, a significantly larger change is seen. When measuring DNA, the 
magnitude of a CD band at 275 nm has been found to be a function of both winding angle and 
twist
64
. The magnitude of the band is directly proportional to the twist angle and inversely 
proportional to the winding angle. Therefore, the IgκB sequence has higher winding and lower 
twist when bound to p65 and Pirin than p65 alone. This effect is also seen with the λ Cro protein, 
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which increases the winding of the specific DNA sequence it binds to and enhances the stability 
of the protein-DNA complex
65
. 
3.3 Bcl-3 interferes with the DNA interaction of the Pirin-p65 complex 
 Since Bcl-3 is required for Pirin to interact with p50 but not p65, it is possible that Bcl-3 
could interfere with the formation of a Pirin-p65 complex through competing for access to the 
same binding region on Pirin or by Bcl-3 interaction altering the conformation of Pirin in such a 
way that it is no longer able to properly interact with p65. To examine this, Pirin was incubated 
with an equimolar concentration of Bcl-3 at room temperature for 10 minutes before adding p65 
to the mixture and flowing it over a QCM-D sensor containing immobilized IgκB DNA. The 
results of this can be seen in Figure 3.5A. Preincubating Pirin with Bcl-3 before adding p65 
resulted in the mass bound to the sensor to dissociate almost immediately upon rinsing with 
buffer, a large contrast to the normally slow dissociation seen with NF-κB-DNA complexes and 
suggestive of a weakly-bound or non-specific interaction. Adding Bcl-3 to p65 without the 
presence of Pirin has no effect on the dissociation of p65 from DNA (Figure 3.5B), consistent 
with the observation that p65 does not interact with Bcl-3.   
 
Figure 3.5: Bcl-3 interferes with Pirin-p65 binding to DNA. (A): Pirin + Bcl-3 + p65, (B): Bcl-3 + p65; 
Blue traces indicate shift in frequency, orange traces indicate shift in dissipation. 5th, 7th, and 9th harmonics used.  
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Interestingly, the almost-complete removal of protein from the sensor surface upon 
rinsing suggests that the Pirin-Bcl-3 complex continues to interact with p65. If no interaction 
between the Pirin-Bcl-3 complex and p65 took place, as would be the case if Bcl-3 and p65 
competed over the same binding region on Pirin, one would expect the Figure 3.5A to look 
similar to Figure 3.5B since neither Pirin or Bcl-3 bind DNA and the p65 would bind to the 
sensor surface as if no other protein was present and would dissociate normally (Figure 3.6A). 
Instead, it appears that the protein complex binding to the DNA in Figure 3.5A is a Pirin-Bcl-3-
p65 complex that has a much lower affinity for DNA as indicated by its lower frequency shift 
(2.01 vs. 3.2) and almost immediate dissociation (Figure 3.6B). An indicator that the protein-
DNA complex formed in Figure 3.5A is different from 3.5B is the spacing of the frequency 
traces of each harmonic. Each harmonic penetrates a certain depth into the biomolecules film 
formed on the QCM sensor surface. Thus, relatively uniform shifts in frequency from each 
harmonic, as seen in Figure 3.5B, indicates a more homogenous layer. Conversely, deviations in 
Δf from one harmonic to another indicate that the mass is not distributed evenly perpendicular to 
the sensor, a characteristic of non-specifically bound protein that is only loosely attaching itself 
to the end of the DNA.  Viscoelastic modeling of shear and viscosity further supports that the 
complex binding DNA in Figure 3.5A is different from a p65 homodimer (Table 3.2). Mixing 
p65 with Bcl-3 alone gives shear and viscosity values that are only about 10-15% less than p65 
alone, suggesting that most of the protein bound to the surface is p65. The small reduction in 
shear and viscosity of the measurement of p65 with Bcl-3 could be attributed to nonspecific 
interaction between Bcl-3 and p65 or the sensor surface. Adding Pirin to the mixture produces 
shear and viscosity values that are very similar to the ones obtained from mixing p65 and Pirin 
alone, indicating that a higher order complex is binding to the DNA. Based on these results, p65 
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and Bcl-3 bind on different regions of Pirin and their interactions are not mutually exclusive. 
Pirin appears to retain its ability to interact with p65 homodimers when bound to Bcl-3, but the 
p65-Pirin-Bcl-3 complex is unable to effectively bind DNA.  
Table 3.2: Shear and viscosity of p65 + Bcl-3 measurements 
 Shear (fold of p65) Viscosity (fold of p65) 
p65 + Bcl-3 0.8298 ± 0.1389 0.8469 ± 0.0414 
p65 + Bcl-3 + Pirin 0.2856 ± 0.0016 0.5326 ± 0.0212 
p65 + Pirin 0.3256 ± 0.0535 0.5051 ± 0.0051 
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Figure 3.6: DNA binding models for Bcl-3 interference with Pirin/p65 interaction. (A) Model 
depicting Bcl-3 directly competing with p65 homodimers for same binding site. Pirin-Bcl-3 complex, unable to bind p65 or 
DNA, would leave p65 on sensor to dissociate slowly; (B) Model depicting Bcl-3 binding to Pirin on a site different from one 
that interacts with p65. Supercomplex forms and binds weakly to sensor but gets washed away by rinsing. (C) Model depicting 
Bcl-3 and p65 being injected together. Bcl-3 does not interact with p65, letting p65 bind normally to the sensor with slow 
dissociation. 
37 
 
 
3.4 Altering the metal-binding environment 
We have previously shown through both SPR and crystallography studies that altering the 
metal-binding environment of Pirin by replacing its iron with other transition metals have 
structural consequences throughout the entire protein and affect the DNA binding affinity of the 
Pirin/NF-κB complex (Liu, unpublished). The structural changes induced by transition metal 
replacement are most likely mediated by alterations in the side-chain positions of the highly-
conserved residues immediately surrounding the metal and its ligands.   
To examine the effects of perturbing the metal-binding environment, two Pirin mutants 
were generated using site-directed mutagenesis: Q115A and W117A. These two residues are not 
metal ligands, but are among the closest non-ligand residues to the iron (Figure 3.1) and show 
100% conservation across all species (Figure 1.3). W117 is located near the protein surface while 
Q115 is further inside the binding pocket and interacts with one of the iron’s water ligands 
through hydrogen bonding.  
 
Figure 3.7: Location of Q115 and W117A residues relative to iron center 
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QCM-D was used to examine the differences in DNA binding and conformation resulting 
from each mutation. Surprisingly, the mutations had different effects when they were combined 
with p50 or p65 (Figure 3.3). When combined with p50 and Bcl-3, the W117A mutant showed a 
reduced level of binding. However, when W117A was in a complex with p65, an opposite trend 
was observed where the binding of the protein complex to the immobilized DNA was nearly 
doubled. Similarly, the Q115A mutant also resulted in an increase of protein binding when 
complexed with p65 but resulted in nearly no effect when combined with p50 and Bcl-3. Thus, 
perturbing the metal-binding environment of Pirin has a different effect upon Pirin’s ability to 
enhance the binding of p50 and p65 and further suggests that Pirin interacts with these two 
homodimers differently.  
 
 
Figure 3.8: Effect of metal-center mutations on p50 and p65 binding 
 
To further examine the differences between the interactions of p50 and p65 with the Pirin 
mutants, the shear and viscosity of each protein-DNA complex was modeled using Q-Tools 
software (Table 3.3). 
39 
 
 
Table 3.3: Viscoelastic properties of mutant-p50/p65 complexes 
 Viscosity (fold of WT) Shear (fold of WT) 
p50 + Bcl-3 + W117A 0.7008 ± 0.0101 0.5553 ± 0.05532 
p50 + Bcl-3 + Q115A 0.9746 ± 0.0547 0.7880 ± 0.1011 
p65 + W117A 0.7320 ± 0.1253 0.5862 ± 0.2597 
p65 + Q115A 0.8526 ± 0.1706 1.033 ± 0.0158 
 
 The Q115A mutant, which did not cause a significant change in the amount of protein 
bound to the immobilized DNA when in a complex with p50 and Bcl-3, has a very similar shear 
and viscosity to the wild-type complex. This suggests that the protein-DNA complex containing 
the Q115A mutant adapts a conformation that is similar to the wild-type complex. The 
similarities between their dissipation vs. frequency plots further support this (Figure 3.4).  The 
W117A-p50 complex, which has significantly reduced shear and viscosity compared to the wild-
type complex, has a noticeably different dissipation vs. frequency plot. Unlike Q115A, this 
mutation appears to affect the conformation of the protein-DNA complex, likely resulting in the 
reduced binding DNA binding affinity seen in Figure 3.3.  
Similar to the Q115A-p50 complex, the Q115A-p65 complex also appears to have a 
similar conformation to the complex containing wild-type Pirin, as evidenced by the nearly 
identical shear, similar viscosity, and the similar overall shape of their dissipation vs. frequency 
plots (Figure 3.9).  
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Figure 3.9: Dissipation vs. frequency plots for p50 and p65 complexes 
  
 The bend in the dissipation vs. frequency plots of the wild-type and Q115A indicates a 
change in the conformation of the layer after a certain amount of binding, going from a relatively 
rigid, organized conformation to a floppier, more disordered conformation with higher 
dissipation. Since both plots bend at roughly the same point (around -10 Hz), it is likely that the 
sensor surface becomes saturated at that point and any additional binding is either unable to take 
the correct conformation due to crowding or is nonspecific binding to the existing layer of 
protein adsorbed to the sensor, causing the sudden upshot in dissipation when the remaining 
proteins bind in a disordered manner on the crowded surface.  Although the assumed ratio of 
protein complexes to DNA molecules is 1:1, the protein complexes are much larger and bulkier 
than the immobilized DNA molecules so surfaces with high densities of immobilized DNA will 
saturate at a protein:DNA ratio that is lower than 1:1. Interestingly, the dissipation vs. frequency 
plot of the W117A-p65 complex does not have this bend, implying that the sensor surface isn’t 
becoming saturated. 
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 To further characterize the differences in DNA binding and conformation, the relative 
thickness of the protein-DNA layer was obtained. Interestingly, the thickness of the layer formed 
by the W117A-p65 complex is nearly twice as thick as the layer formed by the wild-type 
complex. This observation could help explain why W117A-p65 does not experience surface 
saturation. If the protein complex is binding to DNA in such a way that it forms a thicker layer of 
protein, it could mean that the complexes are binding in a disordered manner that does not 
restrict them to a specific sequence on the immobilized DNA strand which would allow for more 
possible binding locations. In correlation with other measurements, the thickness of the layer 
formed by the Q115A-p65 complex resembles the wild-type complex more than it does W117A.  
Table 3.4: Thickness of Pirin mutant complexes with p65 and DNA 
 Thickness (fold of WT+p65) 
p65 + Q115A 1.16 ± 0.22 
p65 + W117A 1.79 ± 0.45 
 
 The CD spectra of the Pirin-p65 complexes were compared to further explore the changes 
in conformation resulting from the Q115A and W117A mutations (Figure 3.10). Measurements 
of Pirin (or its mutant) were taken alongside p65 followed by measurements of each Pirin-p65 
complex. The spectra of Pirin and p65 were subtracted from each Pirin-p65 spectra, leaving 
behind the difference in spectra resulting from the change in secondary structure upon the two 
proteins interacting.  
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Figure 3.10: CD spectra differences of mutant Pirin/p65 complexes 
 
The additional features in the CD spectra of Pirin and p65 upon complex formation are 
very similar to those seen in the formation of a Q115A-p65 complex (Figure 3.10A), supporting 
the QCM data that showed that the Q115A mutant had similar viscoelastic properties (and thus a 
similar conformation) to the wild-type protein. Also consistent with the QCM data was the 
observation that the differences spectrum of the W117A-p65 complex did not follow the same 
trend as the complexes formed from wild-type or Q115A Pirin, its difference spectrum having a 
larger magnitude than those two complexes.  
The effect of IgκB DNA binding upon the conformation of a Pirin-p65 complex and how 
each mutation could affect this was also examined. In this case, DNA binding produced different 
results with each complex (Figure 3.10B). As expected with W117A, the difference spectrum 
showing a decrease in the negative ellipticity of the W117A/p65 complex rather than the increase 
seen with the wild-type and Q115A complexes reveals that this mutation has significant 
consequences on the structure of the protein-DNA complex. While the magnitude of the 
difference spectra of the wild-type and Q115A complexes are similar, the difference spectrum of 
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the Pirin/p65/DNA complex shows a distinct minimum near 224 nm while the difference 
spectrum of the Q115A/p65/DNA complex has a broader minimum ranging from 210-220 nm. 
This finding reveals that, in spite of their similar conformations when bound to p65 alone, DNA 
binding induces a conformational change with the wild-type complex that does not take place in 
the complex containing Q115A.  
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4 DISCUSSION 
Regarding the relationship between the structure and function of Pirin, there are many 
more questions than answers. Our group’s previous research has identified multiple regions of 
interest on Pirin that may be crucial for the protein’s function. In addition to the metal-binding 
environment, there is also the C-terminal α-helix that is present in most eukaryotic Pirin 
homologs but is missing in many of the prokaryotic homologs, as well as the numerous residues 
that line the metal-binding cavity. X-ray crystallography remains the most effective method for 
showing the structural consequences of mutating a given residue. But, with so many potential 
residues and structural features of interest within Pirin, having an alternate and less-costly way to 
study the effects of a mutation upon Pirin’s conformation or behavior with other proteins and 
DNA could allow one to focus their crystallization efforts on the mutants displaying the most 
interesting changes from the wild-type protein. Here, we have shown that a combination of 
QCM-D and CD can be utilized to give an initial characterization of not only the ability of Pirin 
to enhance the DNA binding of NF-κB, but also the differences in conformation of the protein-
protein and protein-DNA complexes. This combination of techniques, which to our knowledge 
has not been utilized in any published study up to this point, could be useful for future structural 
and biochemical studies of Pirin. 
4.1 Differences in interaction with p50 and p65 
So far, Pirin has only been reported in literature as an interactor of p50 and Bcl-3
7
, but we 
have previously demonstrated that it is also capable of interacting with p65 and enhancing its 
affinity for DNA similar to what was observed with p50 (Liu, unpublished). While additional 
proteins outside of Pirin and p65 may be required for transcription on some or all κB promoter 
sites, we have shown that no additional protein such as Bcl-3 is needed for Pirin and p65 to 
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interact. With the p50 complex containing three different proteins and p65 only containing two, 
undoubtedly there are differences between the interactions between these proteins and their 
overall conformation. In this study, we modeled the viscoelastic parameters of each complex 
bound to immobilized DNA and discovered that Pirin greatly increases the shear and viscosity of 
the bound p50-Bcl-3 complex while it reduces these values when complexed with p65. The 
reduced shear and viscosity with p65 can be explained simply by the fact that the addition of 
Pirin makes the protein complex significantly larger, forming a thicker protein layer upon the 
sensor surface that is more likely to contain more trapped water than p65 alone. However, the 
increase in shear and viscosity seen with p50 and Bcl-3 is notable since the addition of Pirin 
would also make this complex larger, but a change in its conformation is taking place that 
compensates for the increased size and makes the protein-DNA layer more rigid and organized. 
This data suggests that Pirin adopts a conformation with p50-Bcl-3 and DNA that contains less 
water than the Pirin-p65-DNA or p50-Bcl-3-DNA complexes, which would produce the changes 
in rigidity and viscosity seen in the viscoelastic modeling.  
Another contributor to the differences in effects of Pirin upon the shear and viscosity of 
p50 and p65, other than the different conformations, is that the p50-Bcl-3-DNA complex is more 
unstable than the p65-DNA complex. As mentioned in Chapter 2, mammalian Bcl-3 normally 
enhances the DNA binding of p50 homodimers. However, this effect is only seen with full-
length Bcl-3 produced in mammalian cells where the protein can be appropriately 
phosphorylated. Our recombinant Bcl-3 protein is truncated at both the N- and C-terminal ends 
and only includes the ARDs and is also obtained from E. Coli, meaning that it is 
unphosphorylated. This truncated, unphosphorylated version of Bcl-3, contrary to its native 
form, has been observed to have an inhibitory effect upon p50-DNA interaction. This could 
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create an unstable protein-DNA complex that is dramatically stabilized by the addition of Pirin, 
contributing the seven-fold increase in shear seen in the viscoelastic modeling results.  
In addition to forming differently shaped complexes, our data shows that p50 and p65 
respond differently to two mutations within the metal-binding environment: Q115A and W117A. 
In particular, the W117A mutation has opposite effects on p50-Bcl-3 and p65, reducing the DNA 
binding of p50 and increasing that of p65. Since Pirin has to interact with both p50 and Bcl-3 to 
form a complex capable of binding DNA, a larger portion of Pirin’s surface would be required to 
form the necessary interactions and thus make a structural change resulting from a mutation 
more likely to have a negative effect. Another possibility, one that was proposed in 2004 in the 
initial crystallization study of Pirin, is that Pirin primarily interacts with Bcl-3 and only has 
limited interactions with p50. If the interaction site for Bcl-3 is different from the interaction site 
for p65, it could allow for a mutation to significantly affect the interaction of one protein but not 
the other.  
4.2 Why might Pirin interact directly with p65 but not p50? 
The RHDs of p50 and p65 have very similar structures and sequences, the primary 
differences being insertions in p50 that give it an additional α-helix in the N-terminal domain and 
a slightly elongated charged loop in the C-terminal domain (Figure 4.1). Since Pirin binds p65 
but not p50, it is likely that the binding interface between the two proteins includes one of these 
regions where there is an insertion in p50 that prevents Pirin from binding to it directly. IκB 
family proteins interact with the C-terminal domain of the RHD, as shown by crystallography
34
 
and studies using truncated p50 to determine the binding location of Bcl-3
47
. Therefore, any  
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Figure 4.1: Sequence and structural alignment of RHD of p50 and p65. p50 represented with orange 
structure, p65 represented with blue structure. p50 insertions in sequence indicated in red, negatively charged loop that is 
proposed to block direct interaction between Pirin and p50 circled. 
 
contact Pirin would have with p50 would be at the C-terminal end of the RHD. If the enhanced 
DNA binding of p65 also results from interaction at the C-terminal domain of the RHD, the 
Pirin-p65 interface is likely to include amino acids 210-220 on p65. In p50, this is where the 
elongated charged loop is, which could cause either steric hindrance, electrostatic repulsion, or a 
combination of the two that would prevent Pirin from binding at that location. An electrostatic 
surface map of Pirin (Figure 4.2) shows that the metal-binding N-terminal domain is negatively 
charged, supporting the hypothesis that electrostatic repulsion prevents Pirin from binding to p50 
directly.  
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Figure 4.2: Electrostatic map of Pirin. Obtained using the PDB2PQR server66 (v.1.8) and visualized in PyMol 
using the Adaptive Poisson-Boltzmann Solver (APBS)67. Protein is rotated 180o between the two panels.  
 
This negatively charged loop on p50 is the most distinct structural feature on the C-
terminal domain of the RHD that is not present on p65 and is used by at least one other protein to 
discriminate between p50 and p65. A binding site of NRF (NF-kappa B repressing factor), which 
interacts with the RHD of p65 but not p50, has been mapped to this region of p65
68
. 
If we assume that this region of NF-κB proteins that contains this negatively charged loop 
on p50 is a crucial factor determining whether Pirin directly interacts with a given NF-κB 
member, we can predict that Pirin would also directly interact with c-rel, which is structurally 
similar to p65 and also lacks the negatively charged loop. p52, which is structurally more similar 
to p50, has the negatively charged loop. Interestingly, p52 is the only other NF-κB member other 
than p50 that interacts with Bcl-3, which makes it possible that Pirin could interact with this 
protein through Bcl-3 in a way similar to p50.  
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4.3 Bcl-3: more than just a bridging molecule 
Every aspect of NF-κB signaling suggests that each part of this elaborate machine is fine-
tuned to only activate a subset of the hundreds of genes containing κB sites, and it is likely that 
Pirin is not an exception. Even though Pirin is capable of enhancing the binding of both p50 and 
p65 homodimers and can interact with a broad range of sequences, that does not necessarily 
mean that the induction of Pirin would result in an enhanced amount of p50 and p65 binding to 
all possible κB sites simultaneously. Other coregulator proteins, such as Bcl-3, may confer 
specificity to Pirin’s effect on NF-κB proteins. Previous studies have demonstrated that Bcl-3 
allows Pirin to interact with p50
7
.  Here, we demonstrate that this interaction with Bcl-3 that 
enables Pirin-p50 complex formation also interferes with Pirin forming a productive DNA-
binding complex with p65 homodimers. This observation suggests a new way in which Bcl-3 
could regulate Pirin activity and, by extension, transcription of κB genes. The simultaneous 
induction of Pirin and Bcl-3 would result in Pirin favoring interaction with p50 homodimers and 
prevent it from enhancing the binding of p65 homodimers. Conversely, reduced levels of Bcl-3 
during Pirin activation would result in unhindered interaction with p65 homodimers and produce 
a different transcription profile. Evidence supporting Pirin’s dual effect as both an activator and 
inhibitor can be seen in Pirin knockout/inhibition studies where differences in gene expression 
are monitored. Pirin inhibition in melanoma cells reduces the expression of IL-8 and CXCL1, 
two genes that are directly regulated by p65
69,70
 and are important mediators of inflammation
71
. 
While this effect could be due to indirect upstream effects of Pirin inhibition, our observation 
that Pirin is capable of influencing the binding behavior of p65 homodimers allows for the 
intriguing possibility that Pirin is directly inhibiting these medically relevant genes.  
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4.4 Structural role of Q115A and W117A 
Q115 and W117 are conserved across all Pirin homologs found in both prokaryotes and 
eukaryotes. These two residues are even found in the truncated Pirin homolog YhhW
18
, which 
does not have Pirin’s C-terminal α-helix and has many other structural features that differ from 
Pirin. Since NF-κB is not present in prokaryotes or many other eukaryotic species that express at 
least one Pirin homolog, these residues are more likely to be needed to maintain the structure of 
the metal-binding cavity and the overall fold of the protein rather than having a function 
specifically related to NF-κB. Here, we showed that the structural changes induced by the 
Q115A and W117A mutations affected Pirin’s interaction with p50 and p65 in different ways. 
The W117A mutation had a greater effect on the structure of the protein than Q115A, based on 
QCM results showing noticeable changes in DNA binding with p50 and p65 and viscoelastic 
modeling showing a greater deviation from the values obtained with wild-type Pirin. CD 
measurements also support a significant deviation from the wild-type structure, showing that 
conformation changes seen in both protein-protein and protein-DNA interactions are altered or 
not present with the W117A mutant. W117’s location near the protein surface, as well as its large 
contribution to the architecture of the metal-binding cavity, makes its large effect on Pirin’s 
structure and protein-protein interactions unsurprising.  However, it’s different effects upon the 
DNA binding of p50 and p65 is more difficult to explain without some speculation.  
We have shown that the W117A mutation nearly doubles the DNA binding of p65 but 
reduces the DNA binding of p50 and Bcl-3 by almost half, further supporting the hypothesis that 
Pirin has different protein-protein interfaces with p50/Bcl-3 and p65 that result in a mutation 
having different conformational consequences for each complex.  The dissipation vs. frequency 
plots for Pirin-p65 complexes in Figure 3.9 showed that the W117A-p65 complex did not 
51 
 
 
saturate the sensor surface at high frequency shifts as the wild-type and Q115A complexes did, 
resulting in the bend in their plot around -10 Hz.  
A possibility for this could be that the W117A-p65 complex binds DNA differently than 
the other complexes, relying more on nonspecific interactions with the DNA backbone than the 
wild-type protein or Q115A and thus giving it more freedom in where it can bind along the DNA 
strand. Figure 4.3A shows the crystal structure of p65 bound to DNA and the bulk of the protein 
compared to the DNA. If the DNA immobilized onto the sensor is densely packed, the binding of 
a Pirin-p65 complex to a specific site on the DNA will discourage other protein complexes from 
binding to the DNA immediately next to it due to crowding, eventually forming an organized 
layer of protein-bound DNA and free DNA (Figure 4.3B). However, if the protein complex isn’t 
constrained to a single binding site, as we are proposing for W117A-p65, and can occupy 
multiple positions on the DNA the bulky protein molecules are less likely to compete for the 
same space, allowing more to be adsorbed to the sensor without it becoming saturated (Figure 
4.3B). This model of interaction explains the lower shear and viscosity produced from modeling 
the W117A-p65-DNA layer, since those values are indicative of a less organized layer such as 
the one that would be formed by more random protein-DNA interactions, as well as the increased 
modeled thickness of the layer. The lack of features in the difference CD spectrum of W117A-
p65-DNA further suggests that the interaction between the protein and DNA is primarily non-
specific and no conformation change is taking place upon DNA binding. The reduction in 
binding of p50 from the W117A mutation could mean that the structural changes caused by the 
W117A mutation affect a part of the protein that is important for p50 or Bcl-3 interaction, thus 
causing the reduced levels of DNA binding, or that the complex forms but is less capable of 
binding to DNA.  
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Figure 4.3: Model of wild-type and W117A Pirin interactions with immobilized DNA  
(A) Crystal structure of p65 bound to DNA (PDB: 1RAM). (B) Model of wild-type (top) and W117A (bottom) Pirin-p65 
complexes interacting with DNA. Wild-type Pirin-p65 interacts with DNA at a specific sequence, excluding binding to 
neighboring DNA due to crowding. W117A-p65 interacts non-specifically with DNA backbone, allowing the proteins to bind in 
multiple places and allowing binding on neighboring strands 
  
The Q115A mutation is somewhat different in nature to the W117A mutation. While 
W117 is likely to have a structural role, mutating Q115 does not appear to have a significant 
effect on the structure of the Pirin-p65 complex. Unlike W117A, the modeled viscoelastic 
parameters of NF-κB complexes containing Q115A are very similar, in some cases practically 
identical, to their wild-type counterpart for both p50 and p65-containing complexes. The features 
of the Q115A + p65 CD difference spectra are also similar to the interaction of wild-type Pirin 
with p65. Based on the bent shape of the dissipation vs. frequency plot of Q115A and p65, the 
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Q115A-p65 complex appears to saturate the sensor surface in a way resembling the wild-type 
complex, implying that a specific DNA site is being bound and the overall architecture of the 
protein-DNA layer is similar to that of the wild-type. However, CD detected subtle differences in 
the conformation of the Q115A-p65-DNA complex from the wild-type complex which suggests 
that, while the Q115A-p65 complex is able to recognize the specific IgκB sequence, it does not 
alter the secondary structure of the DNA the same way. While the Q115A mutation does not 
appear to have significant effects on the overall interaction between Pirin and NF-κB, the 
residue, or perhaps the metal it is indirectly connected to through the water ligand they share an 
interaction with, influences how it interacts in a complex containing DNA.  
4.5 Concluding Remarks 
This study demonstrates the functional importance of non-ligand residues forming the 
metal-binding environment of Pirin. Very little work outside our group has been done on 
studying the relationship between Pirin’s metal and metal-binding environment and its function. 
In metalloproteins, there is often a complex relationship between the chemistry of the metal and 
the structure of the protein. The second-sphere residues of metal-binding sites often have 
important roles in regulating the binding specificity and reactivity of a metal cofactor
72,73
. Thus, 
it makes sense that altering Pirin’s metal-binding environment would result in the conformational 
differences we observed here. 
It is interesting that, in spite of being completely conserved across all species, neither the 
Q115A nor W117A mutation had a negative effect upon the binding of the Pirin-p65 complex to 
IgκB DNA. The W117A-p65 complex appeared to bind more effectively to DNA, but the 
techniques used to characterize the interaction with DNA revealed that the W117A mutation had 
an effect on the conformation of the protein-DNA supercomplex, giving the deleterious effect 
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that one would expect when mutating a conserved residue. This observation would likely have 
gone unnoticed if only traditional techniques to quantify protein-DNA interaction, such as 
EMSA or SPR, were utilized. To our knowledge, this is the first study to combine QCM-D and 
CD to study biomolecular interactions and may provide an avenue in the future to characterize 
other proteins.  
From this study, we can also conclude that the interactions of Pirin with p50 and p65 are 
indeed distinct from each other. Based on QCM-D data, Pirin has a much more pronounced 
effect on the conformation and stability of the p50-Bcl-3-DNA supercomplex than one consisting 
of p65-DNA. Although Pirin increases the binding of both p50 and p65 homodimers, the 
difference in conformation between the two Pirin-NF-κB complexes studied here likely results in 
each complex having a unique set of additional proteins that form the rest of the transcriptional 
machinery. Previous studies suggest that the κB sequence itself also contributes to the role of 
Pirin within a specific gene. Even though Pirin has been shown to interact with p50 and Bcl-3 in 
a gel-mobility shift assay
7
, Pirin knockout/inhibition studies reveal that there are genes regulated 
by p50 and Bcl-3, such as Cyclin-D1 and E-cadherin, which are not affected by the loss of Pirin 
activity
14
 and implies that Pirin is not a required part of every transcriptional complex that 
includes both p50 and Bcl-3. Studying the structure and conformation of Pirin-NF-κB complexes 
on different κB promoter sequences could be a key to bridging a biophysical understanding of 
Pirin to a physiological understanding. 
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APPENDIX A: MATERIALS AND METHODS 
Expression and purification of Pirin: The full length human Pirin plasmid was transformed 
into Escherichia coli strain BL21(DE3) (Invitrogen). Cells were grown at 37°C in Luria-Bertoli 
(LB) media containing 100 μg/ml kanamycin until an absorbance of 0.6-0.8 was achieved. 
Overexpression of Pirin was induced with 0.4 mM isopropyl-β-D-thiogalactopyranoside (IPTG) 
and further grown for 12-16 hours at 28°C before harvesting by centrifugation at 8000 g for 20 
minutes. The supernatant was discarded and the cell pellet was resuspended in 10 ml of lysis 
buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 2 mM EDTA, 0.2 mM phenylmethylsulfonyl 
fluoride (PMSF) and 10 mM β-mercaptoethanol (β-ME) with 5% glycerol) per gram of pellet. 
The fully dissolved cell pellet was then disrupted using a cell press and harvested by 
centrifugation at 27000 g for 30 minutes with the supernatant being kept. Pirin was precipitated 
from the supernatant by adding 55% (w/v) ammonium sulfate. The pellet was harvested by 
centrifugation at 27000 g for 30 minutes and dissolved in 30 ml of buffer A (20 mM Mops, pH 
6.5, with 5% glycerol) and loaded onto a HiLoad 26/40 G-25 desalting column (Amersham 
Pharmacia Biotech) which was pre-equilibrated with buffer A. The protein peak fraction was 
collected and loaded onto SP-Sepharose (Amersham Pharmacia Biotech) cation exchange 
column. The protein was eluted by a linear NaCl gradient from 0 to 200 mM. Peak fractions 
were concentrated with an Amicon concentrator and further polished using Superdex 200 resin 
equilibrated with 20 mM Tris, pH 7.2, 50 mM NaCl with 5% glycerol. The peak fractions were 
once again concentrated and the purity was assessed using SDS-PAGE. 
Expression and purification of p65: The plasmid for the RHD of p65 (amino acids x-xx) 
were transformed into Escherichia coli BL21[DH5α] cells. Cells were grown in LB media at 
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37°C until an absorbance of 0.6-0.8 was reached. p65 overexpression was induced with 0.5 mM 
IPTG followed by overnight incubation at 28°C. Cells were harvested by centrifugation in 8000 
g and 4°C for 15 min. The pellet was resuspended in a lysis buffer of 20 mM Tris–HCl pH 7.4, 
100 mM NaCl, 20 mM β-ME, and 0.1 mM PMSF. The cells were lysed using a cell press and the 
cell debris was removed by centrifugation at 27000 g at 4°C for 30 minutes. The cleared lysate 
was passed through a HiPrep IMAC FF 16/10 Column. The protein was eluted with a linear 
gradient of 50–400 mM imidazole in lysis buffer at 4°C. After further polishing using Superdex 
75 resin, peak fractions were determined by SDS–PAGE and concentrated using an Amicon 
concentrator.  
Expression and purification of p50: The plasmid for the RHD of p50 (amino acids x-xx) 
were transformed into BL21[DH5α] cells. Cells were grown in LB media at 37°C and induced 
with 0.5 mM IPTG upon reaching an OD600 of 0.6. Induced cells were shaken overnight at 28°C 
and harvested by centrifugation in 8000 g and 4°C for 15 min. The pellet was resuspended in 150 
ml lysis buffer (20 mM Tris–HCl pH 6.5, 20 mM β-ME, and 0.1 mM PMSF) and lysed using a 
cell press. Debris was removed by centrifugation at 27 000 g and 4°C for 30 min. The 
supernatant was then passed through a SP-Sepharose Fast Flow cation exchange column 
(Pharmacia). The protein was eluted with a linear gradient of 0–200 mM NaCl in lysis buffer at 
4°C. Peak fractions were identified by SDS–PAGE and concentrated using an Amicon 
concentrator. The peak protein fractions were further polished using a Superdex 75 column 
equilibrated in 20 mM Tris–HCl pH 7.4, 50 mM NaCl and 1 mM DTT.  
Expression and purification of Bcl-3: The plasmid encoding the ankyrin repeat domains of 
Bcl3 (amino acids 119-359) was expressed from a pET11a vector in E. coli stain BL21 (DE3). 
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Cells were grown at 37°C in LB medium containing 100 mg/L ampicillin. Upon an OD600 of 
0.6, protein expression was induced with 0.4 mM IPTG and grown overnight at 25°C before 
harvesting by centrifugation. Cells were resuspended in lysis buffer (20 mM HEPES pH 7.0, 30 
mM NaCl, 5% Glycerol,10 mM dithiothreitol (DTT), 2 mM EDTA,0.2 mM PMSF) and lysed 
using a cell press. Cell debris was removed by centrifugation at 27000 g at 4°C for 30 minutes. 
The protein was precipitated and concentrated by adding 38% (w/v) ammonium sulfate and 
redissolving the salt pellet it in 20 mM Mops pH 6.5, 150 mM NaCl, 3 mM DTT.  The dissolved 
salt pellet was then loaded onto a SP-Sepharose column pre-equilibrated in the previously 
mentioned buffer. The protein was eluted using a 0.15-1.0 M gradient of NaCl. The peak 
fractions were pooled, concentrated with an Amicon concentrator and reloaded onto a Superdex-
75 gel filtration column pre-equilibrated in 25 mM Mops pH 6.5, 50 mM NaCl, and 5 mM DTT. 
The peak fraction was pooled and concentrated using an Amicon concentrator.  
Site-directed mutagenesis: Site-directed mutagenesis was performed using the 
QuikChange Site-Directed Mutagenesis Kit according to the manufacturer’s instructions with the 
plasmid for full-length untagged human Pirin used as the template. For the Q115A mutation, the 
primer sequence 5’GCCCATGGCCTAGCACTGTGGGTTAA -3’ and was used. For W117A, 
the primer sequence 5’-GCCCATGGCCTACAACTGGCGGTTAA -3’ was used. Underlined 
bases indicate the location of the mutation. Pirin mutants were purified using the same procedure 
as the wild-type mutant.  
Sequence alignment: Sequence alignment between two sequences was performed using the 
LALIGN server (http://www.ch.embnet.org/software/LALIGN_form.html) using the default 
settings. For multiple sequences, ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/) was 
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used. For the ClustalW2 alignment, representative Pirin homologs of comparable length (close to 
290 amino acids) were taken from plants, amphibians, fungi, and prokaryotes to ensure a 
diversity of sequences that identified the select few residues that are conserved across all species. 
NCBI numbers of selected sequences are as follows: XePirin (NP_001011440), CapPirin 
(EFW40776), AraPirin (NP_191481), ZeaPirin (NP_001137098). The two prokaryotic 
sequences chosen, “CCPirin” and “P1205Pirin”, have Swiss-prot numbers of P58112 and 
Q9I4D3, respectively. Shorter length Pirin homologs (around 230 amino acids) seen in 
prokaryotes, represented by the E. Coli protein YhhW, have a similar overall fold as Pirin but 
have fundamental differences from the longer length homologs and were not included in the 
alignment.   
Determination of electrostatic maps: Electrostatic maps were created by first generating a 
PQR file using the PDB2PQR server
66
 (http://kryptonite.nbcr.net/pdb2pqr/) using the PARSE 
forcefield. The results were then processed by the APBS web server which generated the 
appropriate files for visualization using PyMol 1.41 and the APBS plugin.  
QCM-D measurements: QCM-D measurements were taken using the Q-Sense E4 system 
with biotin-functionalized sensors (Q-Sense). Biotinylated IgκB DNA (Integrated DNA 
Technologies) was immobilized to the sensor via streptavidin-biotin linkage. For each 
measurement, 500 uL of sample in 50 mM Tris (pH 7.4) with 50 mM NaCl was injected at a 
flow rate of 0.1 mL/min followed by rinsing with buffer. For frequency measurements, the 
frequency shift of the 5
th
 harmonic after buffer rinsing was used. For viscoelastic modeling, 
frequency and dissipation measurements from the 5
th
, 7
th
, and 9
th
 harmonics were used with an 
assumed fluid density of 1020 kg/m
2
 that reflects that the buffer used is slightly denser than 
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water. Surface regeneration was carried out using 0.05% SDS followed by rinsing in buffer until 
the signal stabilized and returned to the baseline.  
Circular dichroism measurements: A buffer of 10 mM sodium phosphate (pH 7.4) and 50 
mM sodium fluoride was used rather than Tris/NaCl buffer since both of those components have 
poor transparency at far-UV wavelengths. For all protein and DNA components used in each 
measurement, 10 μM was used. Samples were scanned five times at 50 nm/min in a 0.1 cm 
cuvette at room temperature with an average of the five scans being used for analysis. All 200-
260 nm spectra shown have had the DNA only spectra subtracted from it while all 240-320 
spectra have the appropriate protein only spectra subtracted. 
APPENDIX B: QCM-D: BACKGROUND AND THEORY 
Quartz crystal microbalance with dissipation (QCM-D) is a relatively new technique that 
has been used to study biological interactions, but the theory of piezoelectricity that it is based on 
has existed for over a hundred years. Piezoelectricity describes the relationship between 
mechanical stress and electric charge where applying an electric current to piezoelectric 
materials, such as quartz crystals, will induce oscillations. The frequency of these oscillations is 
dependent on the thickness of the material. Thus, with all other factors held constant, even a very 
slight change in the thickness of the material resulting from a thin layer being deposited on the 
surface will result in a specific change in the oscillation frequency that can be measured. The 
change in frequency (Δf) can be converted to the mass deposited on the surface using various 
models, creating an ultrasensitive balance capable of accurately measuring in the nanogram 
range that we know today as QCM. 
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QCM has seen increased use over the past decade as its applications have expanded to 
disease diagnosis
74
, study of the interaction of biological molecules
75
, materials science
76
, and 
detection of dangerous or illegal substances
77
. Generally, in the case of disease diagnosis or the 
study of biological molecules, a layer of biomolecules (often antibodies, but can also be other 
proteins or DNA) is immobilized onto the sensor surface that can capture the analyte of interest, 
ideally in a highly specific manner that allows accurate quantification of the analyte of interest 
even when it is in a sample containing many other substances. QCM sensor surfaces are often 
coated in gold to take advantage of the high affinity of thiol groups (-SH) with gold, allowing the 
formation of a self-assembled monolayer (SAM) and relatively simple immobilization of 
anything that can be attached to a linker molecule.  
As a mass attaches itself to the sensor surface a layer is formed, and the properties of this 
layer affect the frequency of a QCM-D sensor in a quantifiable way. The simplest way to 
quantify this relationship between Δf and mass is Sauerbrey’s equation:  
    
    
 
 
where C is equal to 17.7 ng/cm
2
 Hz and n is overtone being measured which allows the change 
in mass on the sensor (Δm) to be obtained from a measured value of Δf78. Sauerbrey’s equation 
is only applicable when the following assumptions are valid: 
1) The mass binding to the sensor must be negligible when compared to the mass of the 
quartz crystal 
2) The binding is evenly distributed across the sensor surface 
3) The mass binding to the sensor must form a thin, rigid layer 
 In most experimental conditions using a properly prepared sensor that has a consistent 
SAM covering its surface, it is safe to assume that the first two conditions are valid. However, 
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for measurements of biomolecules in a liquid phase, the third assumption is no longer valid since 
biomolecules (particularly proteins) form a soft, floppy layer on the surface and the liquid phase 
gets trapped within this layer. At this point, the viscoelastic properties of the layer begin to make 
non-negligible contributions to the frequency, making Sauerbrey’s equation unable to accurately 
describe the relationship between Δf and Δm. A soft, floppy layer adsorbed to a sensor will result 
in a loss of energy during each period of oscillation due to dissipation (D), which can be 
described with the following equation: 
  
 
   
 
where τ is the length of time it takes for an oscillation to decay. Floppier layers that do not move 
uniformly with the sensor as a thin, rigid layer would results in a higher amount of friction and 
energy dissipation and therefore a faster rate of decay for an oscillation. Unlike traditional QCM 
which only measures Δf, QCM-D simultaneously monitors both ΔD and Δf by switching off the 
power driving the oscillation and measuring the decay time (τ) of the signal. By taking into 
account both these parameters, QCM-D allows data obtained from measurements using 
biomolecules to be interpreted more accurately. In cases where biomolecules in a liquid phase 
are being measured and the Sauerbrey model is no longer valid, we turn to the Voigt model 
which accounts for the viscoelastic properties of less rigid layers and can be described as 
follows
79
: 
    
 
      
 
     
     
                  
     
     
 
        
 
      
           
   
where ρ is density, η is viscosity, μ is shear elasticity, δ is thickness, m is mass, and ω is the 
angular frequency of the oscillation. Subscript “q” indicates the quartz crystal, “bulk” indicates 
parameters for the bulk phase, and “layer” indicates parameters for the adsorbed layer on the 
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sensor surface. As you can see, this model is much more complex than the Sauerbrey model and 
accounts for how the bulk solution and the viscoelastic properties of an adsorbed layer (viscosity 
and shear elasticity) influence the frequency.  
While QCM-D has not yet reached the maturity of other biosensing methods such as 
surface plasmon resonance (SPR), its measurement of D offers more insight into the structural 
characteristics of the adsorbed molecules than SPR rather than just quantifying the amount 
adsorbed to the surface. Since D is a reflection of the thickness and rigidity of an adsorbed layer, 
changes in D have been used to monitor the conformation of biomolecules attached to the 
surface in response to changes in solvent or binding a ligand
75. Plotting the ΔD against Δf can 
give a visual representation of how the molecule of interest is attaching to the sensor surface. A 
loose attachment or extended conformation that results in a thicker, more solvated layer will 
have a higher ΔD per unit of Δf and be represented by a steeper slope in the ΔD vs Δf plot. On 
the other hand, a tighter, more rigid layer would have a lower ΔD per unit of Δf and be 
represented by a slope that is nearly flat. Since ΔD/Δf represents the conformation of an 
adsorbed molecule to the sensor surface, it has been used as a “fingerprint” to identify specific 
kinds of substances and interactions.  
By measuring Δf and ΔD and by providing the estimated density of the bulk solution and 
adsorbed protein layer, the shear elasticity and viscosity of the adsorbed layer can be obtained 
using Q-Tools, the data analysis program provided by Q-Sense. These two parameters describe 
the stiffness of the layer and how resistant it is to deformation by shear stress, which occurs as 
the liquid phase flows over the layer attached to the sensor surface. This capability of QCM-D 
has broad applications and is used in this study as a way of further characterizing protein-DNA 
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interactions and using their viscoelastic parameters as an additional way to fingerprint them and 
identify changes in their conformation in response to mutations.  
 
